Northeast Pharma Director Guo Jianmin Plans to Sell Up to 798,800 Shares

Northeast Pharmaceutical announced on September 1 that director Guo Jianmin, who holds 0.2239% of the company's shares, plans to sell no more than 798,800 shares, representing 0.0560% of the company's total share capital, through centralized bidding within three months after 15 trading days.